Blood Specimens - Special Tests: MQ Testing
ShareCompartir
Mefloquine is recommended by CDC as a prophylactic against malaria. When individuals who are presumably on mefloquine prophylaxis exhibit signs of malaria, blood samples are collected and analyzed for the presence of the drug. The drug is extracted from the blood and the concentration is determined by high-performance liquid chromatographic methods. Determining the level of mefloquine in the blood helps assess if the individual was adherent with his/her medication. This procedure is also useful to determine treatment failure due to a mefloquine resistant form of malaria.
DPDx is an education resource designed for health professionals and laboratory scientists. For an overview including prevention and control visit www.cdc.gov/parasites/.
- Page last reviewed: May 3, 2016
- Page last updated: November 13, 2016
- Content source:
- Global Health – Division of Parasitic Diseases and Malaria
- Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.
- Maintained By: